Showing 281-290 of 2874 results for "".
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- Dr. Shiv Sabesan Named CTO at Cytrellishttps://modernaesthetics.com/news/dr-shiv-sabesan-named-cto-at-cytrellis/2473409/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Dr. Arthur Swift is Advanced Medaesthetic Partners’s New CMOhttps://modernaesthetics.com/news/dr-arthur-swift-is-advanced-medaesthetic-partnerss-new-cmo/2473400/Canadian plastic surgeon Arthur Swift, MD, is Advanced Medaesthetic Partners’s new Chief Medical Officer (CMO). “Dr. Swift brings a wealth of knowledge and experience that will be a key asset for our organization,” says Nicole Chiaramonte, AMP CEO, in a news
- Dermalogica Offers Digital Accreditation Badge for Beauty Proshttps://modernaesthetics.com/news/dermalogica-offers-digital-accreditation-badge-for-beauty-profs/2473391/Dermalogica is launching a new medispa accreditation for professional skin therapists. Launching April 17, 2023, the program aims to raise industry standards and provide more transparency to consumers. Unlike state board requirements that lead to esthetics licensing, the
- Binge Watch Alert: The Aesthetic Society Drops New Episodes of Beyond the Before & Afterhttps://modernaesthetics.com/news/binge-watch-alert-the-aesthetic-society-drops-new-episodes-ofbeyond-the-before-after/2473389/The Aesthetic Society dropped four new episodes of their original docuseries 'Beyond the
- Cartessa Aesthetics Names Danica Patrick as VirtueRF Ambassadorhttps://modernaesthetics.com/news/cartessa-aesthetics-names-danica-patrick-as-virtuerf-ambassador/2473388/Former professional racing driver